Free Trial

Procter & Gamble (NYSE:PG) Trading 0.5% Higher - Here's What Happened

Procter & Gamble logo with Consumer Staples background

The Procter & Gamble Company (NYSE:PG - Get Free Report) rose 0.5% during mid-day trading on Wednesday . The stock traded as high as $169.18 and last traded at $168.94. Approximately 2,460,756 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 6,738,386 shares. The stock had previously closed at $168.11.

Analyst Ratings Changes

A number of research analysts recently commented on the company. DA Davidson upgraded Procter & Gamble from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $160.00 to $209.00 in a research note on Monday, November 25th. Barclays lowered shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price target for the company. in a research report on Monday, September 30th. Piper Sandler began coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They issued a "neutral" rating and a $174.00 price objective on the stock. Wells Fargo & Company upped their target price on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an "overweight" rating in a research report on Friday, November 22nd. Finally, Morgan Stanley lifted their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a report on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $180.45.

Check Out Our Latest Stock Analysis on PG

Procter & Gamble Stock Up 0.5 %

The firm has a market capitalization of $397.86 billion, a price-to-earnings ratio of 29.13, a PEG ratio of 3.70 and a beta of 0.44. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The stock has a fifty day moving average of $170.62 and a 200-day moving average of $169.82.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business's revenue for the quarter was down .6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.83 EPS. As a group, sell-side analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $1.0065 dividend. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.38%. Procter & Gamble's payout ratio is currently 69.31%.

Insider Transactions at Procter & Gamble

In related news, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the sale, the chief executive officer now directly owns 269,172 shares in the company, valued at approximately $46,203,373.80. This trade represents a 2.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Susan Street Whaley sold 634 shares of Procter & Gamble stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the sale, the insider now directly owns 19,341 shares of the company's stock, valued at approximately $3,319,882.65. The trade was a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 83,080 shares of company stock valued at $14,629,038 over the last quarter. Company insiders own 0.18% of the company's stock.

Institutional Investors Weigh In On Procter & Gamble

A number of hedge funds and other institutional investors have recently made changes to their positions in PG. Ridgewood Investments LLC acquired a new stake in shares of Procter & Gamble in the second quarter worth about $79,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Procter & Gamble by 8.2% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,103,655 shares of the company's stock worth $182,015,000 after purchasing an additional 83,483 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd grew its holdings in Procter & Gamble by 0.3% during the second quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 40,321 shares of the company's stock valued at $6,650,000 after purchasing an additional 112 shares during the last quarter. FAS Wealth Partners Inc. raised its position in shares of Procter & Gamble by 3.3% in the second quarter. FAS Wealth Partners Inc. now owns 26,327 shares of the company's stock valued at $4,342,000 after purchasing an additional 837 shares during the period. Finally, AM Investment Strategies LLC acquired a new stake in shares of Procter & Gamble in the second quarter worth $226,000. 65.77% of the stock is owned by hedge funds and other institutional investors.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Underrated AI Stocks Set to Surge in 2025
Why Energy Stocks Are Poised for Explosive Growth in 2025
From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines